Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

National Institute for Health and Care Excellence NICE logo

NICE backs PTC’s muscular dystrophy drug Translarna

Drug to be available on the NHS for DMD patients aged five and over

Dr Stephen Hoffman joins Bicycle Therapeutics

He becomes chairman of the board

Lucid Group take time out for work and play at their annual Summer Meeting

Lucid Group may be an award-winning medical education agency, packed with industry-leading talent, but it still understands how important it is to provide the best customer experience possible. 2015 was an...

Lucid Group Communications Limited

- PMLiVE

EU clears AZ’s FDA-rejected diabetes combination

Approval of two-drug therapy Qtern presents first-to-market advantage in Europe

Celgene building

Jounce bags $225m upfront in Celgene immuno-oncology deal

Five pipeline candidate agreement worth up to $2.5bn should Celgene claim the rights

Are you getting these benefits from your digital technology?

Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?

Anthill Agency

- PMLiVE

Virgo Health bolsters digital and creative offering

Nicole Burns and Paul Andrews join the agency

- PMLiVE

Alzheimer’s: the numbers we cannot forget

In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...

Blue Latitude Health

- PMLiVE

International AIDS Society rebrands with focus on patient stories

The Partners Health revamps branding as part of marketing drive

Bristol-Myers Squibb (BMS) building

Opdivo moves closer to head and neck cancer approval

Possible US verdict by November for BMS’ ‘breakthrough’ SCCHN therapy

Novartis Gehry Building

New drugs help Novartis shrug off Gleevec competition

However, warns of lesser profits this year as firm looks to boost promotion of Entresto

- PMLiVE

Decibel Therapeutics appoints former Biogen exec as president and CEO

Steven Holtzman succeeds interim CEO Kevin Starr

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links